Trial intelligence / Profile preview

Duloxetine for postoperative pain after single-segment lumbar fusion in centrally sensitized patients

ChiCTR2000030195Phase 4Recruiting

Sponsor
Third People's Hospital of Chengdu
Start
Feb 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of duloxetine in postoperative pain and chronic low back pain (CLBP) (2 arms), sponsored by Third People's Hospital of Chengdu. Primary endpoint: Pain. Started Feb 2020; status: recruiting.

02

Drugs

duloxetine
03

Conditions

postoperative painchronic low back pain (CLBP)

Beyond the preview

Go deeper on ChiCTR2000030195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000030195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call